- /
- Supported exchanges
- / DU
- / DWD.DU
Morgan Stanley (DWD DU) stock market data APIs
Morgan Stanley Financial Data Overview
There is no Profile data available for DWD.DU.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Morgan Stanley data using free add-ons & libraries
Get Morgan Stanley Fundamental Data
Morgan Stanley Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Morgan Stanley News
New
Morgan Stanley Cuts Tenable (TENB) PT as Cybersecurity Platform Giants Outpace Best-Of-Breed Peers
Tenable Holdings Inc. (NASDAQ:TENB) is one of the best NASDAQ stocks to buy in 2026. On December 18, Morgan Stanley lowered the firm’s price target on Tenable to $30 from $32 with an Equal Weight ra...
Morgan Stanley Reduces PT on Zscaler (ZS) Stock
Zscaler, Inc. (NASDAQ:ZS) is one of the High Growth Large Cap Stocks to Buy Right Now.On December 18, Morgan Stanley reduced the price target on the company’s stock to $305 from $335, while keeping...
Morgan Stanley Cautious on SentinelOne (S) Despite AI Growth, Revenue Beat Due to CFO Transition, Enterprise Sales Cycles
SentinelOne Inc. (NYSE:S) is one of the best low priced technology stocks to buy according to analysts. On December 5, Morgan Stanley lowered the firm’s price target on SentinelOne to $18 from $20 w...
Morgan Stanley Expects Gilead Sciences (GILD) to Thrive as Biopharma Policy Uncertainties Fade in 2026
Gilead Sciences Inc. (NASDAQ:GILD) is one of the best stocks for the next decade. On December 12, Morgan Stanley raised the firm’s price target on Gilead to $151 from $147 with an Overweight rating ...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.